Lantheus Quarterly Cash Flow Statement
NASDAQ: LNTHHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Lantheus free cash flow
In the quarter ended Jun 30, 2026, Lantheus generated $92.2 million of operating cash flow and spent $2.3 million on capital expenditures. That left free cash flow of $89.9 million, a free-cash-flow margin of 23.2% of revenue. Free cash flow was up 13.5% from the prior year's $79.1 million.
Summary generated from market data by MetaCap's automated system. Methodology
Lantheus cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 75.03M | 118.42M | 54.09M | 27.77M | 78.75M | 72.94M | -11.79M | 131.09M | 62.07M | 131.07M | 103.38M | 131.96M |
| Net Income growth (YoY) | -4.73% | +62.34% | — | -78.82% | +26.87% | -44.34% | -111.40% | -0.65% | -34.06% | — | — | +115.50% |
| Depreciation & Amortization | 22.58M | 22.68M | 22.83M | 20.41M | 13.23M | 13.63M | 17.29M | 17.07M | 14.82M | 15.45M | 15.02M | 14.65M |
| Stock-Based Compensation | 20.01M | 16.04M | 17.54M | 24.50M | 22.32M | 21.20M | 22.16M | 20.37M | 18.48M | 15.38M | 14.17M | 13.98M |
| Change in Working Capital | 11.07M | 22.83M | -16.29M | 1.28M | -10.93M | -18.30M | 33.02M | 38.63M | -55.46M | -16.95M | -22.70M | 10.07M |
| Operating Cash Flow | 92.20M | 125.13M | 90.18M | 105.29M | 87.11M | 107.56M | 157.73M | 175.06M | 84.72M | 127.24M | 112.29M | 116.74M |
| Capital Expenditures | -2.33M | -3.23M | -8.79M | -10.62M | -7.96M | -8.72M | -16.37M | -15.81M | -11.18M | -8.27M | 0 | 0 |
| Investing Cash Flow | -2.02M | 25.99M | -11.51M | -319.47M | -232.47M | -63.72M | -6.60M | -67.80M | -45.09M | -106.53M | -12.07M | 83.22M |
| Share Repurchases | — | — | -100.02M | -100.00M | — | — | -100.00M | 0 | — | — | — | — |
| Debt Repaid | -248.00K | -216.00K | -353.00K | -292.00K | -63.00K | -402.00K | 58.00K | 252.00K | -444.00K | -184.00K | -32.00K | -157.00K |
| Financing Cash Flow | 4.50M | -11.62M | -100.79M | -99.17M | -98.41M | -18.22M | -103.66M | 1.87M | 99.00K | -16.84M | -450.00K | 108.00K |
| Net Change in Cash | 94.72M | 139.47M | -22.88M | -313.56M | -242.95M | 25.73M | 46.44M | 109.38M | 38.75M | 4.63M | 99.54M | 200.06M |
| Free Cash Flow | 89.87M | 121.90M | 81.39M | 94.67M | 79.14M | 98.84M | 141.36M | 159.25M | 73.55M | 118.97M | 112.29M | 116.74M |
This table shows 12 quarterly periods of Lantheus's cash flow statement, from Q2 2026 back to Q3 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow LNTH's reporting calendar. What is a cash flow statement?